Read more from our scientific experts and subject matter experts
At Cerba we believe that we are stronger together and that we can grow together. Discover how we are growing and learning first hand with the latest news from Cerba Research!
Biomarker Assay-Driven Clinical Trials
Biomarker assay-driven clinical trials offer researchers a way to gather information on…
Read more
The Role of IHC Assays in Precision Cancer Drug Development
Immunohistology (IHC) assays are a way of visualizing and examining proteins in…
Read more
What are the Stages of Vaccine Development?
Vaccines protect people against infectious diseases. Thanks to rigorous research and testing,…
Read more
How Long is a Vaccine Tested Before FDA Approval?
Vaccines protect us from diseases by teaching our immune systems how to…
Read more
How Are Vaccines Tested?
Vaccines protect the population from outbreaks of diseases. They teach immune systems…
Read more
How to Choose a Central Lab for Clinical Trials
Central laboratory services play a key role in drug development, offering the…
Read more
What is a Central Lab?
Central labs act as a hub for clinical research. These specialized scientific…
Read more
Article – Translating Scientific Questions Into pre-clinical Experiments
Despite global efforts, infectious diseases remain a significant threat to human health…
Read more
Webinar – Advancing CAR T-Cell Therapies with Clinical Trial Customization
Our experts Goran Marinkovic, PhD, Immunologist, Nele Langenaken, General Manager, Dr. Nithianandan Selliah,…
Read more
Viroclinics-DDL changes name to Cerba Research
Viroclinics-DDL a world leading vaccine and antiviral specialty laboratory providing research and clinical trial solutions rooted in virology, proudly announces changing its name to Cerba Research as of the 1st of April 2024. This branding step was an expected move after the Viroclinics-DDL teams had joined Cerba Research in 2022, now operating as one company well positioned in the entire value chain of research and clinical trials.
Read more